- Home
- RLYB vs HUIZ Comparison
RLYB vs HUIZ Comparison
Compare RLYB & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLYB | HUIZ |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7M | 31.5M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RLYB | HUIZ |
|---|---|---|
| Price | $8.67 | $1.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $2.30 |
| AVG Volume (30 Days) | ★ 263.8K | 6.4K |
| Earning Date | 05-07-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $858,000.00 | N/A |
| Revenue This Year | N/A | $22.67 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $7.81 |
| Revenue Growth | ★ 43.00 | N/A |
| 52 Week Low | $0.22 | $1.50 |
| 52 Week High | $11.49 | $4.16 |
Technical Indicators
Market Signals| Indicator | RLYB | HUIZ |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 41.29 |
| Support Level | $0.48 | $1.60 |
| Resistance Level | $11.49 | $2.19 |
| Average True Range (ATR) | 0.69 | 0.11 |
| MACD | -0.41 | 0.01 |
| Stochastic Oscillator | 0.38 | 23.18 |
Price Performance
Historical ComparisonAbout RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.